Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2878)
All Articles published online
|
Apr 14, 2005 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dong M, Ma G, Tu W, Guo KJ, Tian YL, Dong YT. Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer. World J Gastroenterol 2005; 11(14): 2162-2165 [PMID: 15810085 DOI: 10.3748/wjg.v11.i14.2162] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i14/2162.htm |
| Number | Citing Articles |
| 1 |
Jinyun Chen, Christopher I. Amos, Kelly W. Merriman, Qingyi Wei, Subrata Sen, Ann M. Killary, Marsha L. Frazier. Genetic Variants of p21 and p27 and Pancreatic Cancer Risk in Non-Hispanic Whites. Pancreas 2010; 39(1): 1 doi: 10.1097/MPA.0b013e3181bd51c8
|
| 2 |
Kofi Asomaning, Amy E. Reid, Wei Zhou, Rebecca S. Heist, Rihong Zhai, Li Su, Eunice L. Kwak, Lawrence Blaszkowsky, Andrew X. Zhu, David P. Ryan, David C. Christiani, Geoffrey Liu. MDM2 Promoter Polymorphism and Pancreatic Cancer Risk and Prognosis. Clinical Cancer Research 2008; 14(12): 4010 doi: 10.1158/1078-0432.CCR-07-4187
|
| 3 |
Elisa Giovannetti, Valentina Mey, Sara Nannizzi, Giuseppe Pasqualetti, Mario Del Tacca, Romano Danesi. Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer. Molecular Cancer Therapeutics 2006; 5(6): 1387 doi: 10.1158/1535-7163.MCT-06-0004
|
| 4 |
Richard B Halberg, Xiaodi Chen, James M Amos-Landgraf, Alanna White, Kristin Rasmussen, Linda Clipson, Cheri Pasch, Ruth Sullivan, Henry C Pitot, William F Dove. The Pleiotropic Phenotype of Apc Mutations in the Mouse: Allele Specificity and Effects of the Genetic Background. Genetics 2008; 180(1): 601 doi: 10.1534/genetics.108.091967
|
| 5 |
Sumaira Qayoom, Apoorva Agarwal, Preeti Agarwal, Akshay Anand, Rashmi Raj, Sameer Gupta, Ajay Singh. Evaluation of HER2Neu Status in Periampullary Cancers in Tertiary Care Centre in Northern India: A Three-Year Retrospective Study. Cureus 2023; doi: 10.7759/cureus.46646
|
| 6 |
Shih-Hung Yang, Jen-Chieh Lee, Jhe-Cyuan Guo, Sung-Hsin Kuo, Yu-Wen Tien, Ting-Chun Kuo, Ann-Lii Cheng, Kun-Huei Yeh, Ramon Andrade de Mello. Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy. PLOS ONE 2017; 12(7): e0180628 doi: 10.1371/journal.pone.0180628
|
| 7 |
Alexios Strimpakos, Muhammad W. Saif, Kostas N. Syrigos. Pancreatic cancer: from molecular pathogenesis to targeted therapy. Cancer and Metastasis Reviews 2008; 27(3): 495 doi: 10.1007/s10555-008-9134-y
|
| 8 |
Song-bing He, De-chun Li. Mutated genes in pancreatic cancer. Chinese Journal of Cancer Research 2010; 22(2): 93 doi: 10.1007/s11670-010-0093-9
|
| 9 |
Hsi-Feng Tu, Hong-Wen Chen, Shou-Yen Kao, Shu-Chun Lin, Chung-Ji Liu, Kuo-Wei Chang. MDM2 SNP 309 and codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation. Radiotherapy and Oncology 2008; 87(2): 243 doi: 10.1016/j.radonc.2008.03.018
|
| 10 |
Junya Izuhara, Kazuki Kanayama. Impact of LBC Fixative Type and Fixation Time on Molecular Analysis of Pancreatic Cancer Cells. Journal of Cytology 2022; 39(2): 66 doi: 10.4103/joc.joc_13_22
|
| 11 |
Hui Zhang, Xuan Zhang, Xun Li, Wen‐Bo Meng, Zhong‐Tian Bai, Shao‐Zhen Rui, Zheng‐Feng Wang, Wen‐Ce Zhou, Xiao‐Da Jin. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer. Journal of Cellular Physiology 2019; 234(1): 619 doi: 10.1002/jcp.26816
|
| 12 |
Li Jiao, Donghui Li. Molecular Genetics of Pancreatic Cancer. 2013; : 49 doi: 10.1007/978-1-4614-6549-2_3
|
| 13 |
Hohyun Kim, Chan Yong Park, Jae Hyuk Lee, Jung Chul Kim, Chol-Kyoon Cho, Hee Jun Kim. Ki-67 and p53 expression as a predictive marker for early postoperative recurrence in pancreatic head cancer. Annals of Surgical Treatment and Research 2015; 88(4): 200 doi: 10.4174/astr.2015.88.4.200
|
| 14 |
Marketa Hermanova, Petr Karasek, Rudolf Nenutil, Michal Kyr, Jiri Tomasek, Ivana Baltasova, Petr Dite. Clinicopathological Correlations of Cyclooxygenase-2, MDM2, and p53 Expressions in Surgically Resectable Pancreatic Invasive Ductal Adenocarcinoma. Pancreas 2009; 38(5): 565 doi: 10.1097/MPA.0b013e31819fef8b
|
| 15 |
Jan Franko, Alyssa M. Krasinskas, Marina N. Nikiforova, Narcis O. Zarnescu, Kenneth K.W. Lee, Steven J. Hughes, David L. Bartlett, Herbert J. Zeh III, A. James Moser. Loss of Heterozygosity Predicts Poor Survival After Resection of Pancreatic Adenocarcinoma. Journal of Gastrointestinal Surgery 2008; 12(10): 1664 doi: 10.1007/s11605-008-0577-9
|
| 16 |
Lukasz Filip Grochola, Helge Taubert, Thomas Greither, Umesh Bhanot, Andrej Udelnow, Peter Würl. Elevated Transcript Levels From the MDM2 P1 Promoter and Low p53 Transcript Levels Are Associated With Poor Prognosis in Human Pancreatic Ductal Adenocarcinoma. Pancreas 2011; 40(2): 265 doi: 10.1097/MPA.0b013e3181f95104
|
| 17 |
Atsuko Taii, Shinshichi Hamada, Keisho Kataoka, Satoru Yasukawa, Teruhisa Sonoyama, Takeshi Okanoue, Akio Yanagisawa. Correlations Between p53 Gene Mutations and Histologic Characteristics of Pancreatic Ductal Carcinoma. Pancreas 2009; 38(2): e60 doi: 10.1097/MPA.0b013e318197a3f5
|
| 18 |
Yasuki Hori, Katsuyuki Miyabe, Michihiro Yoshida, Takahiro Nakazawa, Kazuki Hayashi, Itaru Naitoh, Shuya Shimizu, Hiromu Kondo, Yuji Nishi, Shuichiro Umemura, Akihisa Kato, Hirotaka Ohara, Hiroshi Inagaki, Takashi Joh, Klaus Roemer. Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma. PLOS ONE 2015; 10(3): e0118829 doi: 10.1371/journal.pone.0118829
|
| 19 |
Yangtao Jin, Ping Zhou, Sisi Huang, Congcong Shao, Dongyan Huang, Xin Su, Rongfu Yang, Juan Jiang, Jianhui Wu. Cucurbitacin B Inhibits the Proliferation of WPMY-1 Cells and HPRF Cells via the p53/MDM2 Axis. International Journal of Molecular Sciences 2024; 25(17): 9333 doi: 10.3390/ijms25179333
|
| 20 |
Vahinipriya Manoharan, Eric Hamilton Karunanayake, Kamani Hemamala Tennekoon, Sumadee De Silva, Ahamed Ilyas Ahamed Imthikab, Kanishka De Silva, Preethika Angunawela, Sameera Vishwakula, John Lunec. Pattern of nucleotide variants of TP53 and their correlation with the expression of p53 and its downstream proteins in a Sri Lankan cohort of breast and colorectal cancer patients. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-6573-5
|
| 21 |
Lukasz F. Grochola, Thomas H. Müller, Gareth L. Bond, Helge Taubert, Andrej Udelnow, Peter Würl. MDM2 SNP309 Associates With Accelerated Pancreatic Adenocarcinoma Formation. Pancreas 2010; 39(1): 76 doi: 10.1097/MPA.0b013e3181b9f105
|
| 22 |
R A Smith, J Tang, C Tudur-Smith, J P Neoptolemos, P Ghaneh. Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. British Journal of Cancer 2011; 104(9): 1440 doi: 10.1038/bjc.2011.110
|
| 23 |
Weiwei Sheng, Ming Dong, Jianping Zhou, Xin Li, Qingfeng Liu, Qi Dong, Feng Li. Cooperation among Numb, MDM2 and p53 in the development and progression of pancreatic cancer. Cell and Tissue Research 2013; 354(2): 521 doi: 10.1007/s00441-013-1679-6
|
| 24 |
Suzanne Russo, Roger Ove, Carlo Contreras, Muhammad Wasif Saif. Adjuvant trials for pancreatic cancer: where are we going and what is needed?. Clinical Investigation 2011; 1(5): 651 doi: 10.4155/cli.11.48
|
| 25 |
Georgios Voidonikolas, Stephanie S. Kreml, Changyi Chen, William E. Fisher, F. Charles Brunicardi, Richard A. Gibbs, Marie‐Claude Gingras. Basic Principles and Technologies for Deciphering the Genetic Map of Cancer. World Journal of Surgery 2009; 33(4): 615 doi: 10.1007/s00268-008-9851-y
|
| 26 |
Weiwei Sheng, Ming Dong, Jianping Zhou, Xin Li, QingFeng Liu, Qi Dong, Feng Li. The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer. Histopathology 2014; 64(4): 523 doi: 10.1111/his.12273
|
| 27 |
Iman Akhlaghipour, Amir Reza Bina, Mohammad Reza Abbaszadegan, Meysam Moghbeli. Methylation as a critical epigenetic process during tumor progressions among Iranian population: an overview. Genes and Environment 2021; 43(1) doi: 10.1186/s41021-021-00187-1
|
| 28 |
Jiwen Dong, Jing Li, Aifang Fu, Huiming Lv. Automatic Segmentation for Ovarian Cancer Immunohistochemical Image Based on YUV Color Space. 2010 International Conference on Biomedical Engineering and Computer Science 2010; : 1 doi: 10.1109/ICBECS.2010.5462327
|
| 29 |
Noushin Taghavi, Firouzeh Biramijamal, Masoud Sotoudeh, Hooman Khademi, Reza Malekzadeh, Omeed Moaven, Bahram Memar, Azadeh A'rabi, Mohammad Reza Abbaszadegan.
p16
INK4a
hypermethylation and p53, p16 and MDM2 protein expression in Esophageal Squamous Cell Carcinoma. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-138
|
| 30 |
Automatic segmentation for ovarian cancer immunohistochemical image based on chroma criterion. 2010 2nd International Conference on Advanced Computer Control 2010; : 147 doi: 10.1109/ICACC.2010.5487198
|
| 31 |
Alexios S. Strimpakos, Kostas N. Syrigos, Muhammad Wasif Saif. The Molecular Targets for the Diagnosis and Treatment of Pancreatic Cancer. Gut and Liver 2010; 4(4): 433 doi: 10.5009/gnl.2010.4.4.433
|
| 32 |
Ming Dong, Qi Dong, Hao Zhang, Jianping Zhou, Yulin Tian, Yuting Dong. Expression of Gadd45a and p53 proteins in human pancreatic cancer: Potential effects on clinical outcomes. Journal of Surgical Oncology 2007; 95(4): 332 doi: 10.1002/jso.20684
|
| 33 |
F. G. Bader, G. Auer, H.-P. Bruch, U.J. Roblick, J.K. Habermann. Hepatobiliäre und Pankreastumoren. 2010; : 38 doi: 10.1007/978-3-642-04935-4_3
|